Philogen

ISIN: IT0005373789 | Ticker: PHIL | LEI: 81560009EA1577917768

Sector: Health Care – Sub-Industry: Biotechnology

Country: Italy

About Philogen

Company Description

Founded in 1996, Philogen is an Italian-Swiss biotechnology company engaged in the discovery and development of biopharmaceutical products for the treatment of life-threatening conditions.

Philogen Group mainly discovers and develops targeted anti-cancer drugs, exploiting high-affinity ligands for tumor markers. These ligands – namely human monoclonal antibodies or small molecules – are identified through Antibody Phage Display Libraries and DNA-Encoded Chemical Libraries technologies. The main therapeutic strategy of the Group for the treatment of these diseases is the so-called “tumor targeting”.

Year founded

1996

Headquarters

Piazza La Lizza 7, 53100 Siena – Italy

Filings & Publications

Insider Trades

Capital markets information

ISIN

IT0005373789

LEI

81560009EA1577917768

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Sub-Industry

Biotechnology

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations department

First name*

Last name*

Your email*

Your phone number

Your company

Your message

I agree to the terms of the privacy policy.*

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.